Hemp and CBD brands need compliance-aware publishers — and should expect thinner inventory, more refusals, and no disease-treatment copy. We do not serve unlicensed medical claims. Approval before publish is mandatory.
CBD prices scarcity and compliance friction. Hemp-industry titles sit below the rare lifestyle rows that will still run non-medical copy, and health-news DoFollow is not a SKU we sell in this category.
CBD link building is where miracle blogs and unsourced 'cures' still get sold as SEO. RankSupply treats it as restricted: thinner sheet, harder outreach, no disease claims, no unlicensed medical positioning. We sell editorial placement on hemp-industry titles and the smaller set of lifestyle or business publications that will run non-medical CBD. You approve every draft — legal should too. Ahrefs-verified. Follow status is labeled; health-adjacent publishers often nofollow or refuse. Replace-or-refund on warrantied URLs. We will not hide a CBD brand inside Beauty, Pet, or Healthcare to dodge this page. Unlicensed 'medical cannabis clinic' copy that is actually drug claims is refused.
Hemp, CBD, and cannabinoid industry titles. The core restricted layer: trade and industry publications that already cover hemp supply, retail, and policy without pretending to be PubMed. Guest posts possible. Follow mixed — labeled. Copy is product-education and industry-ops, not treat-cure. We inspect outbound for pharma-spam and fake-FDA farms. This is still not a volume faucet. Useful for lawful brands and B2B hemp suppliers. Useless as a costume for unlicensed medical clinics. For cbd campaigns this tier is usually fulfilled as a new guest article when you need a fresh topical URL, or as a niche edit when an aged, indexed page already ranks and a contextual insertion is the cleaner job. RankSupply still inspects outbound neighborhoods before stocking, verifies Ahrefs metrics at listing time, and will not swap in a cheaper off-topic blog to decorate Domain Rating on a client PDF.
Lifestyle and wellness titles that accept non-medical CBD. A minority of beauty, fitness, and lifestyle publishers will run CBD if claims stay non-medical. Many will not. We do not bait you with a beauty-pack price and then 'see what happens.' When a row exists, it is on this restricted sheet with claim rules attached. Nofollow is common. Disease language is cut even if the editor would have missed it — we are not interested in being the reason a brand gets an advertising letter. RankSupply still inspects outbound neighborhoods before stocking, verifies Ahrefs metrics at listing time, and will not swap in a cheaper off-topic blog to decorate Domain Rating on a client PDF. You approve topic, anchor, and draft before we pitch; revisions are included until the brief matches, and warrantied live URLs that drop or lose the agreed follow attribute are replaced or refunded.
Regional business and cannabis-adjacent news. State and regional coverage of hemp business, farming, and retail where that coverage is lawful. Follow on news is often nofollow. Geography and licence/legality of the client's offer must match. Colorado and California are not a free pass to write medical claims. UK novel-food context is not a US farm bill context; we match the market. You approve topic, anchor, and draft before we pitch; revisions are included until the brief matches, and warrantied live URLs that drop or lose the agreed follow attribute are replaced or refunded. This is not a volume faucet: if the cbd publisher calendar cannot support the number you already sold, we will say so instead of inventing domains.
National desks. Rare, usually nofollow, often a refuse from the desk. Digital PR is the honest product when it exists. We do not sell medical-news DoFollow packages. Unlicensed and miracle brands never get this far because they fail intake. This is not a volume faucet: if the cbd publisher calendar cannot support the number you already sold, we will say so instead of inventing domains. For cbd campaigns this tier is usually fulfilled as a new guest article when you need a fresh topical URL, or as a niche edit when an aged, indexed page already ranks and a contextual insertion is the cleaner job. RankSupply still inspects outbound neighborhoods before stocking, verifies Ahrefs metrics at listing time, and will not swap in a cheaper off-topic blog to decorate Domain Rating on a client PDF.
FDA, FTC, and UK MHRA/FSA frameworks are not guest-post targets; they are why copy stays in the cosmetic/wellness-of-general-character lane the client can legally occupy. White-label reports never name us. We will not promise a medical-journal or DR 90 DoFollow news homepage. If the product is THC in a legal state market, say so — publisher graphs and rules change, and we may still refuse out-of-state targeting. If the product is a non-CBD beauty SKU, use Beauty. If it is a veterinary drug claim, we refuse.
Refused. Even if a blog would publish it. Especially then.
Those niches will reroute here or decline. Do not brief around the restriction.
If the offer is a drug claim the client cannot make, we will not place it.
The cheapest inventory is the most dangerous. We do not stock it.
A representative scenario built from sheet mechanics — not a named client. Use it to brief your own account team.
An agency represents a US hemp-derived CBD retailer with lawful labeling and no disease claims. A prior vendor used miracle-health blogs and unmarked nofollow. Counsel now wants a screenshot-safe profile.
Entity SEO for cbd means the link source is recognizable to a practitioner in the vertical — associations, trade press, and metros — not a spun blog with a matching keyword in the title.
| Entity | Type | Why it matters for links |
|---|---|---|
| U.S. Food and Drug Administration | Regulator | US FDA cannabis/CBD consumer-update context; we do not write FDA-approved disease claims. |
| Federal Trade Commission | Regulator | US advertising-substantiation context; unsourced health claims are refused. |
| Food Standards Agency (UK) | Regulator | UK CBD novel-food context; British campaigns must match what the client can legally sell and say. |
| MHRA | Regulator | UK medicines regulator; medicinal claims push a product out of this lane into a refuse. |
| U.S. Hemp Roundtable / industry groups | Association | US hemp-industry advocacy context for B2B and policy-education content. |
| Colorado | State market | Mature US hemp/cannabis-adjacent media market; still not a medical-claim free pass. |
| California | State market | Large US market with its own advertising rules; geo and copy must match. |
| Cannabis Business Times | Trade publication | Illustrative industry trade; not a guaranteed SKU and not a medical journal. |
Illustrative rows in the style of the live sheet. Availability moves; request the current cbd tab rather than treating this table as a cart.
| Publication type | Placement | DR band | Notes |
|---|---|---|---|
| Hemp / CBD industry title (illustrative) | Guest post | DR 35–55 | Non-medical copy only. Follow labeled. |
| Lifestyle that accepts non-medical CBD | Guest post | DR 40–55 | Scarce; claims rules attached. Often nofollow. |
| Regional hemp-business news | Editorial | DR 40–60 | Lawful-market match; news often nofollow. |
| Cannabis/hemp trade | Guest post | DR 45–60 | B2B suppliers and retailers; not PubMed. |
| National desk | Digital PR | DR 65–85 | Rare; usually nofollow. Not medical news DoFollow. |
| Aged industry explainer | Niche edit | DR 35–50 | Rare; only on clean, non-miracle URLs. |
New articles on relevant cbd publications. Best when you need a topical URL and a clean contextual link. See guest posting.
Insertions into aged, indexed cbd articles. Faster and cheaper when the page already ranks. See niche edits.
News and syndication when the brand needs visibility more than raw follow. Follow status labeled. See digital PR.
When the client is geo-bound, we add metro news and citations. See local SEO.
CBD wholesale starts around $140 because compliant publishers are scarce and mainstream health titles often refuse the category. Lifestyle rows that will run non-medical copy cost more and are often nofollow. National desks are rare and usually nofollow. Writing is included. Ahrefs metrics are on the sheet. Miracle-health inventory is cheaper and we will not use it. Unlicensed medical-claim briefs are not negotiable on price — they are refused. Do not compare this page's floor to Beauty and assume we will honor a beauty-pack quote for CBD. Content writing is included in the cbd placement price; you are buying outreach, an article a relevant editor will run, and a reported live URL — not a raw link.
Expect fewer monthly URLs than beauty, fitness, or ecommerce. Rejection rates are high when copy drifts toward conditions. A lawful retailer is often well served by a small industry mix plus any explicitly allowed lifestyle rows. We will not hit a twenty-link month with cure blogs. Niche edits are uncommon. Plan slower, budget for nofollow, and put legal on the approval thread from week one. First live cbd URLs land after your approval and the publisher's queue, not overnight, and we would rather miss an arbitrary date than staff junk inventory.
We refuse disease-treatment claims, 'FDA approved' CBD, unlicensed medical clinics, pet diagnose-and-treat copy, and miracle PBNs. We refuse to hide CBD inside Beauty, Pet, Healthcare, or Fitness orders. We refuse to hide nofollow. Rankings are not warrantied. Live URLs we warrant are replaced or refunded. Approval before publish is mandatory. If the product cannot be lawfully marketed as labeled in the target country, do not send the brief. RankSupply will not hide nofollow, will not fabricate customer logos or credentials, and will not guarantee rankings, map-pack positions, or revenue outcomes for cbd clients.
Agencies resell this under their own brand. Reports never say RankSupply. Start from white-label link building, check packages, or build an order.
CBD is a restricted vertical. Inventory is thin, many mainstream and health publishers will not run it, and medical-treatment claims are refused even when a blog would accept them. We fulfill for lawful hemp/CBD marketers in US/UK/Canada frameworks the client can actually stand in — not for unlicensed drug claims, fake 'FDA approved' language, or pet/human diagnose-and-treat copy. We sell editorial placement, not raw links. Ahrefs-verified; follow status labeled (nofollow is common on health-adjacent titles); warrantied URLs are replaced or refunded if they drop. Beauty, pet, and healthcare pages are not a back door for CBD. We will not promise DR 90 DoFollow medical news.
Related vertical — pair campaigns when a client straddles both.
Related vertical — pair campaigns when a client straddles both.
Related vertical — pair campaigns when a client straddles both.
Related vertical — pair campaigns when a client straddles both.
Some hemp-industry placements are DoFollow and warrantied when that is the publisher standard. Health-adjacent and many lifestyle titles are nofollow or refuse CBD entirely. We flag follow status before you order. Anyone promising DoFollow medical news for CBD is selling fiction. On the cbd sheet every row lists follow status before you order, so a nofollow news or magazine feature is never silently mixed into a DoFollow quote.
Paying purely to pass PageRank violates the link spam policy. We sell editorial placement on publications that choose to run non-medical CBD copy. Restricted verticals get tighter claim control, not looser spam standards. Follow is labeled. Paying a vendor solely to pass PageRank is against Google's link spam policy; RankSupply sells outreach and editorial placement on real cbd publications that choose to run the piece.
Yes. Agencies keep their brand. Reports never mention RankSupply. Counsel should sit on approval; we will wait for that sign-off rather than 'just publish.' Most cbd volume is agencies serving their own clients under their own brand: reports, bylines when requested, and delivery emails never say RankSupply. That is the fulfillment model for US, UK, and Canadian SEO firms that already sold the retainer and need a desk that will not leak onto the client's Slack.
Yes, included. Non-medical product and industry education. You approve topic, anchor, and draft. We will not write treat/cure language even if a blog would accept it. Writing is included in the cbd placement price. Drafts are written to the audience of that publication type, not keyword-stuffed, and you approve topic, anchor, and the full article before we pitch. Revisions run until the brief matches. We will not invent credentials, case results, clinical claims, or customer logos the client cannot defend.
Low. A handful of clean placements is a serious month. If you already sold a beauty-style volume pack for CBD, unwind it. We quote against restricted inventory, not a number on a DTC deck. Honest cbd volume is whatever the real publisher set can support without repeating domains or substituting junk. A single destination URL rarely needs a twenty-link month; hubs, geos, and product lines can absorb more if we split targets.
No. Those pages will reroute or refuse medical and CBD-specific claims. Brief this restricted lane so everyone sees the constraints up front. For cbd specifically, RankSupply still sells outreach and editorial placement rather than raw links, with approval before publish and Ahrefs-verified rows on the sheet. Follow status is labeled, including nofollow when that is the publisher's standard, and warrantied live URLs are replaced or refunded if they drop.
Refused. Licensed-where-required, lawful labeling, no disease claims. If the offer is a drug, we are the wrong vendor — and a guest post will not make it a lawful drug. For cbd specifically, RankSupply still sells outreach and editorial placement rather than raw links, with approval before publish and Ahrefs-verified rows on the sheet. Follow status is labeled, including nofollow when that is the publisher's standard, and warrantied live URLs are replaced or refunded if they drop.
No. National health desks rarely run CBD commercial copy, and when they mention the category it is often nofollow journalism. We do not sell that fantasy. Industry titles and careful lifestyle rows are the honest inventory. On the cbd sheet every row lists follow status before you order, so a nofollow news or magazine feature is never silently mixed into a DoFollow quote.
Named domains, Ahrefs metrics, wholesale rates. Same-day reply from the founder.